APA (7th ed.) Citation

Oliva, A., Volpicelli, L., Di Bari, S., Curtolo, A., Borrazzo, C., Cogliati Dezza, F., . . . Venditti, M. (2022). Effect of ceftazidime/avibactam plus fosfomycin combination on 30 day mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae: Results from a multicentre retrospective study. JAC-antimicrobial resistance, 4(6), dlac121. https://doi.org/10.1093/jacamr/dlac121

Chicago Style (17th ed.) Citation

Oliva, A., et al. "Effect of Ceftazidime/avibactam Plus Fosfomycin Combination on 30 day Mortality in Patients with Bloodstream Infections Caused by KPC-producing Klebsiella Pneumoniae: Results from a Multicentre Retrospective Study." JAC-antimicrobial Resistance 4, no. 6 (2022): dlac121. https://doi.org/10.1093/jacamr/dlac121.

MLA (9th ed.) Citation

Oliva, A., et al. "Effect of Ceftazidime/avibactam Plus Fosfomycin Combination on 30 day Mortality in Patients with Bloodstream Infections Caused by KPC-producing Klebsiella Pneumoniae: Results from a Multicentre Retrospective Study." JAC-antimicrobial Resistance, vol. 4, no. 6, 2022, p. dlac121, https://doi.org/10.1093/jacamr/dlac121.